These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36527508)

  • 41. Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women.
    Liu S; Chen R; Ding N; Wang Q; Huang M; Liu H; Xie Z; Ou Y; Sheng Z
    J Endocrinol Invest; 2021 Feb; 44(2):347-352. PubMed ID: 32495298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study.
    Leslie WD; Möller S; Skjødt MK; Yan L; Abrahamsen B; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA; Rubin KH
    Osteoporos Int; 2022 Jul; 33(7):1457-1463. PubMed ID: 35175395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine.
    Povoroznyuk V; Grygorieva N; Johansson H; Lorentzon M; Harvey NC; McCloskey EV; Musienko A; Liu E; Kanis JA; Zaverukha N; Ivanyk O
    J Osteoporos; 2021; 2021():2043479. PubMed ID: 34194719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of spine-hip discordance on fracture risk assessment and treatment qualification in Canada: the Manitoba BMD registry.
    Leslie WD; Morin SN; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):85. PubMed ID: 32514615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
    Holloway-Kew KL; Zhang Y; Betson AG; Anderson KB; Hans D; Hyde NK; Nicholson GC; Pocock NA; Kotowicz MA; Pasco JA
    Osteoporos Int; 2019 Oct; 30(10):2129-2139. PubMed ID: 31317250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sri Lankan FRAX model and country-specific intervention thresholds.
    Lekamwasam S
    Arch Osteoporos; 2013; 8():148. PubMed ID: 23975235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of FRAX without BMD: an age-related analysis of the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010).
    Kim JW; Koh JM; Park JH; Chang JS
    Bone; 2015 Jun; 75():27-31. PubMed ID: 25697083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
    Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45&Up Study cohort.
    Chen JS; Simpson JM; Blyth FM; March LM
    Bone; 2014 Dec; 69():148-53. PubMed ID: 25263521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
    Silva DMW; Borba VZC; Kanis JA
    Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
    Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
    J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. At Odds About the Odds: Women's Choices to Accept Osteoporosis Medications Do Not Closely Agree with Physician-Set Treatment Thresholds.
    Billington EO; Feasel AL; Kline GA
    J Gen Intern Med; 2020 Jan; 35(1):276-282. PubMed ID: 31625042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of screening tools for optimizing fracture prevention in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 Oct; 15(1):170. PubMed ID: 33111193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.
    Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES;
    Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.
    Ström O; Jönsson B; Kanis JA
    Osteoporos Int; 2013 Apr; 24(4):1491-502. PubMed ID: 23224141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical risk factor status in patients with vertebral fracture but normal bone mineral density.
    Kadri A; Binkley N; Daffner SD; Anderson PA
    Spine J; 2022 Oct; 22(10):1634-1641. PubMed ID: 35680015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid: A nationwide osteoporosis survey.
    Yu SF; Chen JF; Chen YC; Lai HM; Ko CH; Chiu WC; Su FM; Hsu CY; Su BY; Wu CH; Cheng TT
    Medicine (Baltimore); 2017 Feb; 96(5):e5959. PubMed ID: 28151883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted vertebral fracture assessment for optimizing fracture prevention in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 May; 15(1):65. PubMed ID: 32363426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.